Search results for "Drug Safety"


 
Results 21 - 30 of about 34 for "Drug Safety".
Sort by: Relevance | Newest | Oldest

Latest diabetes drugs have a learning curve

The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015

Changes to contraindication for statins in pregnancy

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/09/changes-to-contraindication-for-statins-in-pregnancy.htm
1 Sep 2021

Warning on PPIs and C. diff, contraceptive pill mixup

Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/04/fda.htm
1 Apr 2012

Pulmonary illnesses linked to e-cigarette products

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/11/pulmonary-illnesses-linked-to-e-cigarette-products.htm
1 Nov 2019

Polypill gets approval, fenofibric acid gets label change

Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/01/fda.htm
1 Jan 2012

Ranitidine pulled from market; COVID-19 updates

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/06/ranitidine-pulled-from-market-covid-19-updates.htm
1 Jun 2020

Expanded approval on rivaroxaban, reassurance on dabigatran

This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013

Recommended: Move hydrocodone combo products to schedule II

This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014

New COPD treatment, warnings on insomnia and migraine drugs

This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more.
https://immattersacp.org/archives/2013/07/fda.htm
1 Jul 2013

New warning for testosterone, approval for inhaled insulin

This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014

Result Page: Prev   1   2   3   4   Next